Peritoneal sarcomatosis: Is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?

Annals of Surgical Oncology

Volumn 17, Issue 12, 2010, Pages 3220-3228

  Baratti, Dario ^a   Pennacchioli, Elisabetta ^a   Kusamura, Shigeki ^a   Fiore, Marco ^a   Balestra, Maria Rosaria ^a   Colombo, Chiara ^a   Mingrone, Elvira ^a   Alessanrdro, Gronchi ^a   Deraco, Marcello ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; MITOMYCIN C;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; CANCER SURVIVOR; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DUODENUM PERFORATION; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; LEIOMYOSARCOMA; LIPOSARCOMA; MALE; MORBIDITY; NEPHROTOXICITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PERITONEAL SARCOMATOSIS; PERITONEUM CANCER; RANDOMIZED CONTROLLED TRIAL; SARCOMA; SMALL INTESTINE PERFORATION;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; CISPLATIN; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; LEIOMYOSARCOMA; LIPOSARCOMA; MALE; MIDDLE AGED; MITOMYCIN; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PROSPECTIVE STUDIES; RETROPERITONEAL NEOPLASMS; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE NEOPLASMS; YOUNG ADULT;

EID: 78650973415     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1178-x     Document Type: Article

References (40)

1. Brennam MF, Singer S, Maki RG. Soft tissue sarcoma. In: De Vita VT, Lawrence TS, Rosemberg SA, editors. Cancer: principles and practice of oncology. 8th edition. New York: Lippincott Williams and Wilkins; 2008:1741.
2. CP Karakousis LE Blumensou G Canavese U Rao 1992 Surgery for disseminated abdominal sarcoma Am J Surg 163 560 564 1:STN:280:DyaK383otV2rtQ%3D%3D 10.1016/0002-9610(92)90556-7 1375814
3. MM Billimoria DJ Holtz NQ Mirza, et al. 2002 Tumor volume as a prognostic factor for sarcomatosis Cancer 94 2441 2446 10.1002/cncr.10504 (Pubitemid 34457126)
4. JO Park LX Qin FP Prete C Antonescu MF Brennan S Singer 2009 Predicting outcome by growth rate of locally recurrent retroperitoneal liposarcoma: the one centimeter per month rule Ann Surg 250 977 982 10.1097/SLA.0b013e3181b2468b 19953716
5. GD Demetri M von Mehern CD Blanke, et al. 2002 Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors N Engl J Med 347 472 480 1:CAS:528:DC%2BD38XmtV2nt7s%3D 10.1056/NEJMoa020461 12181401 (Pubitemid 34879334)
6. PH Sugarbaker 1995 Peritonectomy procedures Ann Surg 221 29 42 1:STN:280:DyaK2M7is1OhsQ%3D%3D 10.1097/00000658-199501000-00004 7826158
7. PH Sugarbaker 2006 New standard of care for appendiceal epithelial neoplasm with pseudomyxoma peritonei syndrome Lancet Oncol 1 69 76 10.1016/S1470-2045(05)70539-8 (Pubitemid 43025395)
8. TD Yan M Deraco D Baratti, et al. 2009 Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma: Multi-Institutional Experience J Clin Oncol 27 6237 6242 10.1200/JCO.2009.23. 9640 19917862
9. D Elias F Gilly F Boutitie, et al. 2010 Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study J Clin Oncol 28 63 68 10.1200/JCO.2009.23.9285 19917863
10. L Bijelic A Jonson PH Sugarbaker 2007 Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer Ann Oncol 18 1943 1950 1:STN:280:DC%2BD2sjktVGmtA%3D%3D 10.1093/annonc/mdm137 17496308 (Pubitemid 350286229)
11. CR Rossi PG Casali S Kusamura D Baratti M Deraco 2008 The consensus statement on the locoregional treatment of abdominal sarcomatosis J Surg Oncol 94 291 294 10.1002/jso.21067
12. CP Karakousis K Karakousis DL Driscoll 1997 Intraperitoneal chemotherapy in disseminated abdominal sarcoma Ann Surg Oncol 4 496 498 1:STN:280: DyaK2svlsV2gsQ%3D%3D 10.1007/BF02303674 9309339
13. FC Eilber G Rosen C Forscher SD Nelson FJ Dorey FR Eilber 1999 Surgical resection and intraperitoneal chemotherapy for recurrent abdominal sarcomas Ann Surg Oncol 6 645 650 1:STN:280:DC%2BD3c%2FitlGjtw%3D%3D 10.1007/s10434-999-0645- 8 10560849
14. B Berthet TA Sugarbaker D Chang PH Sugarbaker 1999 Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment Eur J Cancer 35 413 419 1:STN:280:DyaK1MznslCjsw%3D%3D 10.1016/S0959-8049(98)00375-X 10448292 (Pubitemid 29151938)
15. CR Rossi M Deraco M De Simone, et al. 2004 Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients Cancer 100 1943 1950 10.1002/cncr.20192 15112276 (Pubitemid 38529572)
16. JLG Sabrido E Velasco Sanchez, et al. 2006 Intensification terapeutica intraoperatoria en el tratamiento de los sarcomas abdominles localmente avanzados Cir Esp 80 200 205 10.1016/S0009-739X(06)70958-7
17. SJ Lim JN Cormier BW Feig, et al. 2007 Toxicity and outcomes associated with surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with sarcomatosis Ann Surg Oncol 14 2309 2318 10.1245/s10434-007-9463-z 17541691 (Pubitemid 47174932)
18. S Bonvalot A Cavalcanti C Le Pechoux, et al. 2005 Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis Eur J Surg Oncol 31 917 923 1:STN:280:DC%2BD2MrhtlaltQ%3D%3D 10.1016/j.ejso.2005.04.010 15975759 (Pubitemid 41435263)
19. NJ Gusani SW Cho C Colovos, et al. 2007 Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center Ann Surg Oncol 15 754 763 10.1245/s10434-007-9701-4 18080166
20. A Hayes-Jordan P Anderson P Curley, et al. 2007 Continuous hyperthermic peritoneal perfusion for desmoplastic small round cell tumor J Pediatr Surg 42 29 32 10.1016/j.jpedsurg.2007.05.047 (Pubitemid 47238357)
21. MM Oken RH Creech DC Tormey, et al. 1982 Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 649 655 1:STN:280:DyaL3s7kvFOgsw%3D%3D 10.1097/00000421-198212000-00014 7165009
22. S Kusamura D Baratti R Younan, et al. 2007 Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity Ann Surg Oncol 14 2550 2558 10.1245/s10434-007-9429-1 17558537 (Pubitemid 47393524)
23. Kusamura S, Raspagliesi F, Baratti D, Gronchi A, Casali P, Deraco M. Uterine sarcoma treated by cytoreductive surgery and intraperitoneal hyperthermic perfusion: a feasibility study. J Chemother. 2004;16 S5:19-22.
24. P Jaquet PH Sugarbaker 1996 Current methodologies for clinical assessment of patients with peritoneal carcinomatosis J Exp Clin Cancer Res 15 49 58
25. M Deraco D Baratti S Kusamura B Laterza MR Balestra 2009 Surgical technique of parietal and visceral peritonectomy for peritoneal surface malignancies J Surg Oncol 100 321 328 10.1002/jso.21388 19697439
26. CR Rossi M Foletto S Mocellin, et al. 2002 Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study Cancer 94 492 499 1:CAS:528:DC%2BD38XhtV2qs7k%3D 10.1002/cncr.10176 11900234 (Pubitemid 34081381)
27. Fletcher CD, Unni K, Mertens K. Pathology and genetics of tumours of soft tissues and bone. In: Kleihves D, Sobin LH, editors. World Health Organization of Tumour. Lyon, France International Agency for Research on Cancer, 2002.
28. M Trojani G Contesso JM Coindre, et al. 1984 Soft-tissue sarcomas of adults: Study of pathological prognostic variables and definition of a histopathological grading system Int J Cancer 33 37 42 1:STN:280: DyaL2c7htVKhuw%3D%3D 10.1002/ijc.2910330108 6693192
29. C Mussi P Collini R Miceli, et al. 2008 The prognostic impact of dedifferentiation in retroperitoneal liposarcoma: a series of surgically treated patients at a single institution Cancer 113 1657 1665 10.1002/cncr.23774 18704991
30. C Fletcher J Berman C Corless, et al. 2002 Diagnosis of gastrointestinal stromal tumors: a consensus approach Hum Pathol 33 478 483 10.1053/hupa.2002. 124123 (Pubitemid 34747866)
31. P Therasse SG Arbuck EA Eisenhauer, et al. 2000 New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 205 216 1:STN:280:DC%2BD3c7it1Gitg%3D%3D 10.1093/jnci/92.3.205 10655437
32. EL Kaplan P Meier 1958 Nonparametric estimation from incomplete observations J Am Stat Soc 53 457 481
33. DR Cox 1972 Regression models and life tables (with discussion) J R Stat Soc B 34 187 220
34. EH Ng RE Pollock MM Romsdahl 1992 Prognostic implications of patterns of failure for gastrointestinal leiomyosarcomas Cancer 69 1334 1341 1:STN:280:DyaK387nsVSmtQ%3D%3D 10.1002/1097-0142(19920315)69:6<1334::AID- CNCR2820690606>3.0.CO;2-S 1540870
35. RP DeMatteo JJ Lewis D Leung SS Mudan JM Woodruff MF Brennan 2000 Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival Ann Surg 231 51 58 1:STN:280:DC%2BD3c7gtVSmtQ%3D%3D 10.1097/00000658-200001000-00008 10636102 (Pubitemid 30043939)
36. R O'Cearbhaill ML Hensley 2010 Optimal management of uterine leiomyosarcoma Expert Rev Anticancer Ther 10 153 169 10.1586/era.09.187 20131992
37. O Zivanovic MM Leitao A Iasonos, et al. 2009 Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the International Federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems J Clin Oncol 27 2066 2072 10.1200/JCO.2008.19.8366 19255317
38. ML Hensley JA Blessing R Mannel, et al. 2008 Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial Gynecol Oncol 109 329 334 1:CAS:528:DC%2BD1cXmvVKrsLw%3D 10.1016/j.ygyno.2008.03.010 18534250 (Pubitemid 351754961)
39. ML Hensley JA Blessing K Degeest O Abulafia PG Rose HD Homesley 2008 Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study Gynecol Oncol 109 323 328 1:CAS:528:DC%2BD1cXmvVKrsL8%3D 10.1016/j.ygyno.2008.02.024 18394689
40. MM Leitao MF Brennan M Hensley, et al. 2002 Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma Gynecol Oncol 87 287 294 10.1006/gyno.2002.6840 12468327 (Pubitemid 36034649)